The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
The hands are a common predilection site of atopic dermatitis (AD). Dupilumab is licensed for the treatment of AD but not for chronic hand eczema (CHE), while CHE is challenging to treat.
Objectives
To evaluate the long‐term effect of dupilumab on hand eczema (HE) in patients with AD from the BioDay Registry.
Methods
A prospective observational study of adult patients with HE, treated...
Background
The CARPE registry was set up in 2009 to prospectively investigate the management of patients with chronic hand eczema (CHE).
Objectives
To report comprehensive follow‐up data from the CARPE registry.
Patients and methods
We investigated sociodemographic and clinical characteristics, provision of medical care, physician‐assessed outcomes, and patient‐reported outcomes (PROs). Data...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.